Melanotan I vs II China Supplier: Buyer Guide

Do not treat Melanotan I and II as synonyms

Create separate specifications and purchase-order lines. Require the full name, approved abbreviation, molecular reference, purity target, 10mg nominal content and research-use status. Roman numeral, capital-I and lowercase-l errors can make product codes look nearly identical. The supplier must confirm each identity in writing and apply distinct labels and lot records.

Normalize marketplace names before comparison

Translate MT1, MT-1, Melanotan I, MT2 and Melanotan II into the buyer’s controlled naming table without assuming equivalence. Ask the supplier to map its product code to the exact material and analytical sample. Do not allow photographs, cap colors or shared category tags to serve as identification. Resolve spelling discrepancies across quote, COA, label and packing list before payment.

Require separate analytical evidence for each material

Review HPLC and MS evidence for the exact Melanotan I or Melanotan II lot. One material’s report cannot represent the other. Check expected molecular information, chromatogram, sample ID, test date and authorization. A report showing high chromatographic purity does not demonstrate that the other peptide was not packed accidentally; label and reconciliation controls remain necessary.

Verify the 10mg statement

Both catalog pages use a 10mg presentation, but equal nominal strength does not make the materials interchangeable. Ask which quantitative method or filling control supports content and what tolerance applies. Confirm total vials and quantity basis. Separate identity, purity and content in the comparison matrix so the shared 10mg label cannot obscure different molecular products.

Control packaging and receiving mix-ups

Require clearly differentiated product names, lot numbers and box labels. Ask how line clearance, component issuance and quantity reconciliation prevent swaps. For mixed orders, obtain a product-by-product packing list and finished-package photographs where appropriate. Receiving staff should inspect representative units and quarantine any label, cap or lot inconsistency until a traceable explanation is approved.

Map the supplier and batch ownership chain

Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner and dispatch entity for the exact SKU. A supplier can coordinate qualified partners, but the arrangement and responsibilities should be transparent. Ask who releases the batch, who investigates deviations and who retains original production and test records. Require notification before a critical party changes. This supply-chain map helps buyers distinguish technical control from a generic factory claim and clarifies which company is accountable when labels, documents or received quantities do not match the approved order.

Build one comparable wholesale quotation matrix

Send every supplier the same fields: exact identity, strength, vial count, total material, target purity, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, lead time and shipping term. Mark missing answers as exceptions rather than filling gaps with assumptions. Separate one-time testing or setup costs from recurring unit costs. This creates one auditable decision record for scientific, purchasing and quality reviewers and prevents the lowest-looking offer from winning simply because it describes less work.

Apply a batch-focused quality-control review

Define methods and acceptance criteria before purchase. HPLC commonly supports chromatographic purity and mass spectrometry can support identity, but neither should imply untested attributes. Check sample identifiers, dates, report numbers, units and lot relationships. Use the quality-control framework to connect each claim to evidence. Preserve original reports, record revisions and investigate contradictions before accepting the lot.

Create a documentation gate before dispatch

List the required COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ. Reconcile product, strength, lot, quantity and revision across documents using the documentation guide. The importer remains responsible for current destination rules. Research-use wording supports clarity but neither guarantees customs entry nor replaces destination-specific due diligence.

Qualify logistics and receiving controls

Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject promises of guaranteed clearance or misleading declarations. On receipt, record package condition, seals, product, strength, lot and quantity, then link internal inventory to the supplier batch. Quarantine unexplained discrepancies until a documented quality decision is completed.

Use actual performance for repeat-order approval

A controlled evaluation order should use the same specification planned for wholesale scale. Assess document accuracy, package condition, delivery time, communication and corrective response, and consider buyer-arranged testing appropriate to risk with documented sample custody. For every new lot, repeat the batch review. Require notification before changes to manufacturing, testing, filling, material specification, labels or packaging.

Related products and same-category guides

• Melanotan I 10mg
• Melanotan II 10mg
• Semax vs Selank China Supplier Guide
• Lot Traceability Checklist

Frequently asked questions